Bezafibrate 13C6

[13C6]-Bezafibrate is a chemical compound with molecular formula C19H20ClNO4S and a molecular weight of 421.93 g/mol. It is a stable isotope labeled analog of Bezafibrate, a medication used to treat high cholesterol and triglycerides. [13C6]-Bezafibrate is often used in research studies to track the metabolism and pharmacokinetics of Bezafibrate in vivo. The compound is commonly used in pharmacokinetic studies to track the movement and metabolism of Bezafibrate in living organisms. The stable isotope labeling of [13C6]-Bezafibrate allows researchers to differentiate it from the non-labeled compound using mass spectrometry. This enables researchers to track the metabolism of Bezafibrate in vivo and determine how it is distributed, metabolized, and excreted from the body. [13C6]-Bezafibrate is a safe compound to use in research studies, as it does not have any known toxic effects. It is typically administered through injection or oral ingestion in animal studies. The compound is stable and does not degrade under normal laboratory conditions, making it a reliable tool for tracking the pharmacokinetics of Bezafibrate. Overall, [13C6]-Bezafibrate is a valuable tool in pharmacokinetic research, providing insights into the metabolism and distribution of Bezafibrate in living organisms. Its stable isotope labeling enables researchers to accurately track the compound's movement and metabolism, allowing for a better understanding of how the medication works in the body.